Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-4-16
pubmed:abstractText
Although axillary lymph nodes status, tumour size, hormonal-receptor status and histological grade at diagnosis are frequently used to orient the treatment of breast cancer patients, some tumours recur in patients with early stage disease. Pre-operative assessment of individual tumour characteristics, based on oncogenes and growth factors related to tumour growth, invasion or metastasis, may guide the treatment for patients with breast carcinomas.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Actins, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1, http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activators, http://linkedlifedata.com/resource/pubmed/chemical/Platelet-Derived Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/RNA-Directed DNA Polymerase, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0748-7983
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
28-33
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:9542512-Actins, pubmed-meshheading:9542512-Blotting, Southern, pubmed-meshheading:9542512-Breast Neoplasms, pubmed-meshheading:9542512-Cyclin D1, pubmed-meshheading:9542512-DNA Primers, pubmed-meshheading:9542512-Endothelial Growth Factors, pubmed-meshheading:9542512-Female, pubmed-meshheading:9542512-Gene Expression Regulation, Neoplastic, pubmed-meshheading:9542512-Humans, pubmed-meshheading:9542512-Lymphokines, pubmed-meshheading:9542512-Plasminogen Activators, pubmed-meshheading:9542512-Platelet-Derived Growth Factor, pubmed-meshheading:9542512-Polymerase Chain Reaction, pubmed-meshheading:9542512-Prognosis, pubmed-meshheading:9542512-RNA, Messenger, pubmed-meshheading:9542512-RNA, Neoplasm, pubmed-meshheading:9542512-RNA-Directed DNA Polymerase, pubmed-meshheading:9542512-Receptor, erbB-2, pubmed-meshheading:9542512-Vascular Endothelial Growth Factor A, pubmed-meshheading:9542512-Vascular Endothelial Growth Factors
pubmed:year
1998
pubmed:articleTitle
Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential.
pubmed:affiliation
First Department of Surgery, Kyushu University Faculty of Medicine, Fukuoka, Japan.
pubmed:publicationType
Journal Article